Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate.

Cheng JM, Dangerfield EM, Timmer MS, Stocker BL.

Org Biomol Chem. 2014 May 7;12(17):2729-36. doi: 10.1039/c4ob00241e.

PMID:
24652424
2.

Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.

Chen W, Xia C, Wang J, Thapa P, Li Y, Talukdar A, Nadas J, Zhang W, Zhou D, Wang PG.

J Org Chem. 2007 Dec 21;72(26):9914-23. Epub 2007 Nov 17. Erratum in: J Org Chem. 2008 Jun 20;73(12):4762. Talukdar, Arindam [added].

PMID:
18020363
3.

Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells.

Xia C, Schümann J, Emmanuel R, Zhang Y, Chen W, Zhang W, De Libero G, Wang PG.

J Med Chem. 2007 Jul 26;50(15):3489-96. Epub 2007 Jul 4.

PMID:
17608465
4.

CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells.

Sanderson JP, Brennan PJ, Mansour S, Matulis G, Patel O, Lissin N, Godfrey DI, Kawahara K, Zähringer U, Rossjohn J, Brenner MB, Gadola SD.

Eur J Immunol. 2013 Mar;43(3):815-25. doi: 10.1002/eji.201242952. Epub 2013 Jan 31.

5.

Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.

Yin N, Long X, Goff RD, Zhou D, Cantu C 3rd, Mattner J, Mezard PS, Teyton L, Bendelac A, Savage PB.

ACS Chem Biol. 2009 Mar 20;4(3):199-208. doi: 10.1021/cb800277n.

6.

Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.

Shang P, Zhang C, Xia C, Chen W, Han Q, Wang PG, Zhang J, Tian Z.

Int Immunopharmacol. 2008 May;8(5):645-53. doi: 10.1016/j.intimp.2008.01.003. Epub 2008 Feb 12.

PMID:
18387506
7.

Enhanced antitumor effects by chemical modified IGb3 analogues.

Zhou Z, Zhang C, Xia C, Chen W, Zhu H, Shang P, Ma F, Wang PG, Zhang J, Xu W, Tian Z.

Mol Cancer Ther. 2011 Aug;10(8):1375-84. doi: 10.1158/1535-7163.MCT-11-0030. Epub 2011 Jun 8.

8.

Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells.

Xia C, Zhou D, Liu C, Lou Y, Yao Q, Zhang W, Wang PG.

Org Lett. 2006 Nov 23;8(24):5493-6.

PMID:
17107055
9.

Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells.

Yu ED, Girardi E, Wang J, Zajonc DM.

J Immunol. 2011 Sep 1;187(5):2079-83. doi: 10.4049/jimmunol.1101636. Epub 2011 Aug 1.

10.

Enzymatic synthesis of Gb3 and iGb3 ceramides.

Adlercreutz D, Weadge JT, Petersen BO, Duus JØ, Dovichi NJ, Palcic MM.

Carbohydr Res. 2010 Jul 2;345(10):1384-8. doi: 10.1016/j.carres.2010.02.006. Epub 2010 Feb 13.

11.

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.

Porubsky S, Speak AO, Luckow B, Cerundolo V, Platt FM, Gröne HJ.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5977-82. Epub 2007 Mar 19.

12.

Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids.

Zajonc DM, Savage PB, Bendelac A, Wilson IA, Teyton L.

J Mol Biol. 2008 Apr 4;377(4):1104-16. doi: 10.1016/j.jmb.2008.01.061. Epub 2008 Jan 31.

13.

Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.

Porubsky S, Speak AO, Salio M, Jennemann R, Bonrouhi M, Zafarulla R, Singh Y, Dyson J, Luckow B, Lehuen A, Malle E, Müthing J, Platt FM, Cerundolo V, Gröne HJ.

J Immunol. 2012 Sep 15;189(6):3007-17. doi: 10.4049/jimmunol.1201483. Epub 2012 Aug 8.

14.

Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).

Xia C, Yao Q, Schümann J, Rossy E, Chen W, Zhu L, Zhang W, De Libero G, Wang PG.

Bioorg Med Chem Lett. 2006 Apr 15;16(8):2195-9. Epub 2006 Feb 2.

PMID:
16458002
15.

Chemoenzymatic syntheses of iGb3 and Gb3.

Yao Q, Song J, Xia C, Zhang W, Wang PG.

Org Lett. 2006 Mar 2;8(5):911-4.

PMID:
16494472
16.

[Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].

Porubsky S, Luckow B, Bonrouhi M, Speak A, Cerundolo V, Platt F, Gröne HJ.

Pathologe. 2008 Nov;29 Suppl 2:297-302. doi: 10.1007/s00292-008-1040-0. German.

PMID:
18810447
17.

The immunological function of iGb3.

Zhou D.

Curr Protein Pept Sci. 2006 Aug;7(4):325-33. Review.

PMID:
16918447
18.

Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.

Pellicci DG, Clarke AJ, Patel O, Mallevaey T, Beddoe T, Le Nours J, Uldrich AP, McCluskey J, Besra GS, Porcelli SA, Gapin L, Godfrey DI, Rossjohn J.

Nat Immunol. 2011 Jul 31;12(9):827-33. doi: 10.1038/ni.2076.

PMID:
21804559
19.

Species-specific activity of glycolipid ligands for invariant NKT cells.

Dangerfield EM, Cheng JM, Knight DA, Weinkove R, Dunbar PR, Hermans IF, Timmer MS, Stocker BL.

Chembiochem. 2012 Jun 18;13(9):1349-56. doi: 10.1002/cbic.201200095. Epub 2012 May 25.

PMID:
22639457
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk